At Douglas CDMO, every client is a priority.
We support softgel and lipophilic programs from early development through tech transfer, scale-up, and commercial supply, with clear communication, and predictable timelines.
Why choose a specialist CDMO
Every project brings its own level of complexity. But they all require focus.
At Douglas, our structure is designed to keep our customers close to the science, giving you direct access to decision makers and senior experts, along with the focus and attention to maintain momentum at every stage.
Softgel and lipophilic expertise for complex molecules
Douglas CDMO is a specialist in softgel and lipid based formulation, supporting programs including high potency molecules from early fit assessment through scale-up and commercial readiness. Our scientists work directly with your team to ensure your molecule progresses with confidence.
Our capabilities include:
- Lipid-based formulation expertise: solving solubility and bioavailability challenges for complex molecules
- End-to-end development support: from pre-formulation and early clinical through to commercial readiness
- Analytical and stability capability: methods, validation, and studies aligned to lipid-based systems
- Scale-up and technical transfer: robust processes from development to PPQ and commercial manufacture
- Commercial supply and lifecycle management: validated processes, global launch support, and ongoing optimisation
Quality you can rely on
Quality is built into every stage of our work. Our systems are designed to operate to GMP standards, with clear and complete documentation and well controlled processes that stand up to regulatory scrutiny.
With consistent standards from early development through to commercial supply, we help you move forward with confidence.
Your experience working with Douglas CDMO
Your project moves through a structured, expert-led pathway designed to maintain clarity, continuity, and momentum. By minimising handoffs and aligning teams early, we reduce complexity and avoid downstream rework.
You work directly with named specialists, ensuring clear communication, continuity, and confidence at every stage.
Whether you’re a lean biotech or a larger organisation bringing a specialised dosage form into your portfolio, Douglas CDMO provides focus and technical depth from early development through tech transfer, scale up and commercial supply.
As a specialist CDMO, we bring together agility and deep softgel expertise to support complex molecules with focus and precision.
Recognition and awards
The FDA’s Quality Management Maturity Pilot Study
In 2024, Douglas was one of only nine companies worldwide selected to participate in the FDA’s QMM pilot study.